There are 3161 resources available
1800P - Breaking chemo-immunotherapy resistance in SCLC-patient derived tumor with novel DDRi combinations
Presenter: Carminia Della Corte
Session: Poster session 07
1801P - Expression analysis of Fuc-GM1 ganglioside in first-line therapy for extensive-stage small cell lung cancer (ES-SCLC) with BMS-986012, nivolumab, and carboplatin-etoposide
Presenter: Kenneth O'Byrne
Session: Poster session 07
1802P - Cost-effectiveness study of atezolizumab (ATZ) vs. durvalumab (DUR) in elderly extensive disease small cell lung cancer (ED-SCLC) patients (pts): Real-world data (RWD) on first-line chemotherapy combined with immune-checkpoint inhibitors (Chemo-ICIs)
Presenter: Ken Yamamoto
Session: Poster session 07
1803P - Analysis of samples from the SCLC REACTION trial: Discovery of biomarkers to optimize treatment
Presenter: Pernelle Lavaud
Session: Poster session 07
1805P - PKD1L1 mutations in small cell lung cancer: A genomic signature for poor prognosis and drug susceptibility
Presenter: Ning Tang
Session: Poster session 07
Resources:
Abstract
1806P - Clinical characteristics and management of small cell lung cancer long survivors
Presenter: Elisa Gobbini
Session: Poster session 07
1807P - Spatial analyses revealed MMP7 as the biomarker of tumor boundary correlated with immune resistance in small cell lung cancer
Presenter: Le Tang
Session: Poster session 07
1809P - Validation of the lung inmune prognostic (LIPI) index in first-line immunotherapy treatment of small cell lung carcinoma
Presenter: Patricia Cruz Castellanos
Session: Poster session 07